Medincell Aktie
| 35,66EUR | -1,94EUR | -5,16% |
WKN DE: A2N6VA / ISIN: FR0004065605
Personal
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 148 | 149 | 143 | 134 | 140 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,06 | 0,03 | 0,07 | 0,07 | 0,18 |
Bilanz (in Mio. EUR) - Aktiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 56 | 34 | 20 | 27 | 81 |
| Summe Anlagevermögen | 7 | 10 | 10 | 10 | 10 |
| Summe Aktiva | 64 | 44 | 29 | 37 | 90 |
Bilanz (in Mio. EUR) - Passiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 55 | 58 | 72 | 78 | 107 |
| Summe Eigenkapital | 9 | -13 | -42 | -41 | -16 |
| Summe Passiva | 64 | 44 | 29 | 37 | 90 |
Adresse
| 3, rue des Frères Lumière, 34830 Jacou | |
| Internet | http://www.medincell.com |
Management
|
Adolfo Lopez-Noriega
Head-Research & Development |
|
Charles Kunsch
Independent Director |
|
Christophe Douat
Chief Executive Officer & Director |
|
Christophe Roberge
Technical Director |
|
Elisabeth Kogan
Member-Supervisory Board |
|
Franck Pouzache
Chief People Officer |
|
Grace Kim
Investors Relations Contact |
|
Julie Alimi
Head-Legal |
|
Pascal Touchon
Independent Director |
|
Philippe Guy
Chairman-Supervisory Board |
|
Richard Malamut
Chief Medical Officer |
|
Sharon L. Mates
Independent Director |
|
Stéphane Postic
Chief Financial Officer |
|
Sébastien Enault
Chief Business Officer |
|
Sébastien Magnat
Head-Operations |
|
Tone Kvåle
Member-Supervisory Board |
|
Virginie Lleu
Member-Supervisory Board |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.